רנקסה 1000 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
RANOLAZINE 1000 MG
Available from:
NEOPHARM LTD
ATC code:
C01EB18
Pharmaceutical form:
TABLETS EXTENDED RELEASE
Administration route:
PER OS
Manufactured by:
CV THERAPEUTICS INC, USA
Therapeutic group:
RANOLAZINE
Therapeutic indications:
Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
Authorization date:
2010-10-01
